FDA — authorised 10 January 2020
- Application: ANDA212280
- Marketing authorisation holder: CIPLA
- Status: supplemented
FDA authorised pregabalin capsules on 10 January 2020
Yes. FDA authorised it on 10 January 2020.
CIPLA holds the US marketing authorisation.